Searching for source:FDA

1,984 results
Record publications over time
Ironsift results are limited for unregistered users. Register or log in to see all records.

US Drug Approval A062171 – FDA – Mar 31, 1982

Optomycin

1 approved drug product. Optomycin Ingredients: Chloramphenicol; Dosage form: solution/drops; Route of administration: ophthalmic; Strength: 0.5%; Approval date: March 31, 1982; Marketing status: discontinued.
Full record

US Drug Approval A062178 – FDA – Jan 1, 1982

Grisactin Ultra

2 approved drug products. Grisactin Ultra Ingredients: Griseofulvin, Ultramicrocrystalline; Dosage form: tablet; Route of administration: oral; Strength: 125mg; Approval date: prior to January 1, 1982; Marketing status: discontinued. Grisact...
Full record

US Drug Approval A062206 – FDA – Apr 20, 1988

Cefaclor

4 approved drug products. Cefaclor Ingredients: Cefaclor; Dosage form: for suspension; Route of administration: oral; Strength: eq 125mg base/5ml; Approval date: prior to January 1, 1982; Marketing status: discontinued. Cefaclor Ingredient...
Full record

US Drug Approval A062233 – FDA – Jan 1, 1982

Cloxapen

2 approved drug products. Cloxapen Ingredients: Cloxacillin Sodium; Dosage form: capsule; Route of administration: oral; Strength: eq 250mg base; Approval date: prior to January 1, 1982; Marketing status: discontinued. Cloxapen Ingredients...
Full record

US Drug Approval A062237 – FDA – Jan 1, 1982

Erythromycin Estolate

1 approved drug product. Erythromycin Estolate Ingredients: Erythromycin Estolate; Dosage form: capsule; Route of administration: oral; Strength: eq 250mg base; Approval date: prior to January 1, 1982; Marketing status: discontinued.
Full record

US Drug Approval A062270 – FDA – Jan 1, 1982

Beepen-Vk

2 approved drug products. Beepen-Vk Ingredients: Penicillin V Potassium; Dosage form: for solution; Route of administration: oral; Strength: eq 125mg base/5ml; Approval date: prior to January 1, 1982; Marketing status: discontinued. Beepen-V...
Full record

US Drug Approval A062291 – FDA – Jan 1, 1982

Cefadroxil

1 approved drug product. Cefadroxil Ingredients: Cefadroxil/Cefadroxil Hemihydrate; Dosage form: capsule; Route of administration: oral; Strength: eq 500mg base; Approval date: prior to January 1, 1982; Marketing status: discontinued.
Full record

US Drug Approval A062303 – FDA – Jan 1, 1982

Rifadin

1 approved drug product. Rifadin Ingredients: Rifampin; Dosage form: capsule; Route of administration: oral; Strength: 150mg; Approval date: prior to January 1, 1982; Marketing status: prescription.
Full record

US Drug Approval A062304 – FDA – Jan 1, 1982

Pediamycin and Pediamycin 400

2 approved drug products. Pediamycin Ingredients: Erythromycin Ethylsuccinate; Dosage form: suspension; Route of administration: oral; Strength: eq 200mg base/5ml; Approval date: prior to January 1, 1982; Marketing status: discontinued. Pedi...
Full record

US Drug Approval A062326 – FDA – Apr 19, 1982

Erythromycin

1 approved drug product. Erythromycin Ingredients: Erythromycin; Dosage form: solution; Route of administration: topical; Strength: 2%; Approval date: April 19, 1982; Marketing status: discontinued.
Full record

US Drug Approval A062328 – FDA – Apr 19, 1982

Erythromycin

1 approved drug product. Erythromycin Ingredients: Erythromycin; Dosage form: solution; Route of administration: topical; Strength: 1.5%; Approval date: April 19, 1982; Marketing status: discontinued.
Full record
Register to view full records and receive email notifications.

US Drug Approval A062336 – FDA – Mar 10, 1988

Mutamycin

3 approved drug products. Mutamycin Ingredients: Mitomycin; Dosage form: injectable; Route of administration: injection; Strength: 5mg/vial; Approval date: prior to January 1, 1982; Marketing status: discontinued. Mutamycin Ingredients: Mi...
Full record

US Drug Approval A062347 – FDA – Mar 30, 1987

Nystatin and Triamcinolone Acetonide

1 approved drug product. Nystatin and Triamcinolone Acetonide Ingredients: Nystatin; Triamcinolone Acetonide; Dosage form: cream; Route of administration: topical; Strength: 100,000 units/gm;0.1%; Approval date: March 30, 1987; Marketing statu...
Full record

US Drug Approval A062351 – FDA – Feb 18, 1982

Gentamicin Sulfate

1 approved drug product. Gentamicin Sulfate Ingredients: Gentamicin Sulfate; Dosage form: ointment; Route of administration: topical; Strength: eq 0.1% base; Approval date: February 18, 1982; Marketing status: prescription.
Full record

US Drug Approval A062354 – FDA – Apr 5, 1982

Gentamicin Sulfate

1 approved drug product. Gentamicin Sulfate Ingredients: Gentamicin Sulfate; Dosage form: injectable; Route of administration: injection; Strength: eq 40mg base/ml; Approval date: April 5, 1982; Marketing status: discontinued.
Full record

US Drug Approval A062366 – FDA – Aug 4, 1983

Gentamicin Sulfate

2 approved drug products. Gentamicin Sulfate Ingredients: Gentamicin Sulfate; Dosage form: injectable; Route of administration: injection; Strength: eq 10mg base/ml; Approval date: February 6, 1986; Marketing status: prescription. Gentamicin...
Full record

US Drug Approval A062383 – FDA – Aug 31, 1982

Neomycin Sulfate and Polymyxin B Sulfate Gramicidin

1 approved drug product. Neomycin Sulfate and Polymyxin B Sulfate Gramicidin Ingredients: Gramicidin; Neomycin Sulfate; Polymyxin B Sulfate; Dosage form: solution/drops; Route of administration: ophthalmic; Strength: 0.025mg/ml;eq 1.75mg base/ml...
Full record

US Drug Approval A062392 – FDA – Mar 31, 1983

Doxycycline Hyclate

2 approved drug products. Doxycycline Hyclate Ingredients: Doxycycline Hyclate; Dosage form: tablet; Route of administration: oral; Strength: eq 50mg base; Approval date: March 31, 1983; Marketing status: discontinued. Doxycycline Hyclate...
Full record

US Drug Approval A062396 – FDA – May 7, 1984

Doxycycline Hyclate

2 approved drug products. Doxycycline Hyclate Ingredients: Doxycycline Hyclate; Dosage form: capsule; Route of administration: oral; Strength: eq 50mg base; Approval date: November 7, 1984; Marketing status: prescription. Doxycycline Hyclate...
Full record

US Drug Approval A062406 – FDA – Nov 9, 1982

Chloramphenicol

1 approved drug product. Chloramphenicol Ingredients: Chloramphenicol Sodium Succinate; Dosage form: injectable; Route of administration: injection; Strength: eq 1gm base/vial; Approval date: November 9, 1982; Marketing status: discontinued.
Full record

US Drug Approval A062408 – FDA – Aug 31, 1982

Ultracef

1 approved drug product. Ultracef Ingredients: Cefadroxil/Cefadroxil Hemihydrate; Dosage form: tablet; Route of administration: oral; Strength: eq 1gm base; Approval date: August 31, 1982; Marketing status: discontinued.
Full record
Register to view full records and use our APIs.

US Drug Approval A062413 – FDA – Aug 11, 1983

Gentamicin Sulfate

10 approved drug products. Gentamicin Sulfate Ingredients: Gentamicin Sulfate; Dosage form: injectable; Route of administration: injection; Strength: eq 1.2mg base/ml; Approval date: August 11, 1983; Marketing status: discontinued. Gentamici...
Full record

US Drug Approval A062423 – FDA – Aug 25, 1983

Neomycin and Polymyxin B Sulfates and Hydrocortisone

1 approved drug product. Neomycin and Polymyxin B Sulfates and Hydrocortisone Ingredients: Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate; Dosage form: solution/drops; Route of administration: otic; Strength: 1%;eq 3.5mg base/ml;10,000 un...
Full record

US Drug Approval A062427 – FDA – May 26, 1983

Gentamicin Sulfate

1 approved drug product. Gentamicin Sulfate Ingredients: Gentamicin Sulfate; Dosage form: cream; Route of administration: topical; Strength: eq 0.1% base; Approval date: May 26, 1983; Marketing status: discontinued.
Full record

US Drug Approval A062430 – FDA – Apr 8, 1983

Ocumycin

1 approved drug product. Ocumycin Ingredients: Bacitracin Zinc; Polymyxin B Sulfate; Dosage form: ointment; Route of administration: ophthalmic; Strength: 500 units/gm;10,000 units/gm; Approval date: April 8, 1983; Marketing status: discontinu...
Full record

US Drug Approval A062447 – FDA – Sep 26, 1983

Erythromycin

1 approved drug product. Erythromycin Ingredients: Erythromycin; Dosage form: ointment; Route of administration: ophthalmic; Strength: 0.5%; Approval date: September 26, 1983; Marketing status: prescription.
Full record

US Drug Approval A062452 – FDA – Oct 10, 1984

Genoptic

1 approved drug product. Genoptic Ingredients: Gentamicin Sulfate; Dosage form: solution/drops; Route of administration: ophthalmic; Strength: eq 0.3% base; Approval date: October 10, 1984; Marketing status: prescription.
Full record

US Drug Approval A062459 – FDA – Nov 9, 1983

Nystatin

1 approved drug product. Nystatin Ingredients: Nystatin; Dosage form: tablet; Route of administration: vaginal; Strength: 100,000 units; Approval date: November 9, 1983; Marketing status: discontinued.
Full record

US Drug Approval A062464 – FDA – May 7, 1984

Cephalothin Sodium

3 approved drug products. Cephalothin Sodium Ingredients: Cephalothin Sodium; Dosage form: injectable; Route of administration: injection; Strength: eq 1gm base/vial; Approval date: May 7, 1984; Marketing status: discontinued. Cephalothin So...
Full record

US Drug Approval A062467 – FDA – Jul 3, 1985

E-Solve 2

1 approved drug product. E-Solve 2 Ingredients: Erythromycin; Dosage form: lotion; Route of administration: topical; Strength: 2%; Approval date: July 3, 1985; Marketing status: discontinued.
Full record

US Drug Approval A062468 – FDA – Jul 3, 1985

C-Solve-2

1 approved drug product. C-Solve-2 Ingredients: Erythromycin; Dosage form: solution; Route of administration: topical; Strength: 2%; Approval date: July 3, 1985; Marketing status: discontinued.
Full record
Register to view full records and advanced analytics.

US Drug Approval A062469 – FDA – Oct 31, 1984

Doxycycline Hyclate

2 approved drug products. Doxycycline Hyclate Ingredients: Doxycycline Hyclate; Dosage form: capsule; Route of administration: oral; Strength: eq 50mg base; Approval date: October 31, 1984; Marketing status: discontinued. Doxycycline Hyclate...
Full record

US Drug Approval A062474 – FDA – Dec 22, 1983

Nystatin

1 approved drug product. Nystatin Ingredients: Nystatin; Dosage form: tablet; Route of administration: oral; Strength: 500,000 units; Approval date: December 22, 1983; Marketing status: prescription.
Full record

US Drug Approval A062500 – FDA – Sep 11, 1984

Doxycycline Hyclate

2 approved drug products. Doxycycline Hyclate Ingredients: Doxycycline Hyclate; Dosage form: capsule; Route of administration: oral; Strength: eq 50mg base; Approval date: September 11, 1984; Marketing status: prescription. Doxycycline Hycla...
Full record

US Drug Approval A062505 – FDA – Sep 11, 1984

Doxycycline Hyclate

1 approved drug product. Doxycycline Hyclate Ingredients: Doxycycline Hyclate; Dosage form: tablet; Route of administration: oral; Strength: eq 100mg base; Approval date: September 11, 1984; Marketing status: prescription.
Full record

US Drug Approval A062517 – FDA – Jun 7, 1984

Nystatin

1 approved drug product. Nystatin Ingredients: Nystatin; Dosage form: suspension; Route of administration: oral; Strength: 100,000 units/ml; Approval date: June 7, 1984; Marketing status: prescription.
Full record

US Drug Approval A062519 – FDA – Jul 6, 1984

Nystex

1 approved drug product. Nystex Ingredients: Nystatin; Dosage form: suspension; Route of administration: oral; Strength: 100,000 units/ml; Approval date: July 6, 1984; Marketing status: discontinued.
Full record

US Drug Approval A062521 – FDA – Jul 11, 1985

Otocort

1 approved drug product. Otocort Ingredients: Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate; Dosage form: suspension/drops; Route of administration: otic; Strength: 1%;eq 3.5mg base/ml;10,000 units/ml; Approval date: July 11, 1985; Mar...
Full record

US Drug Approval A062522 – FDA – Jan 24, 1985

Sansac

1 approved drug product. Sansac Ingredients: Erythromycin; Dosage form: solution; Route of administration: topical; Strength: 2%; Approval date: January 24, 1985; Marketing status: discontinued.
Full record

US Drug Approval A062540 – FDA – Mar 21, 1985

Tetracycline Hydrochloride

2 approved drug products. Tetracycline Hydrochloride Ingredients: Tetracycline Hydrochloride; Dosage form: capsule; Route of administration: oral; Strength: 250mg; Approval date: March 21, 1985; Marketing status: discontinued. Tetracycline H...
Full record

US Drug Approval A062558 – FDA – Mar 15, 1985

Erythromycin Ethylsuccinate

1 approved drug product. Erythromycin Ethylsuccinate Ingredients: Erythromycin Ethylsuccinate; Dosage form: suspension; Route of administration: oral; Strength: eq 400mg base/5ml; Approval date: March 15, 1985; Marketing status: discontinued....
Full record
Register to view full records and disable ads.

US Drug Approval A062560 – FDA – Sep 10, 1985

Mandol

2 approved drug products. Mandol Ingredients: Cefamandole Nafate; Dosage form: injectable; Route of administration: injection; Strength: eq 1gm base/vial; Approval date: September 10, 1985; Marketing status: discontinued. Mandol Ingredient...
Full record

US Drug Approval A062569 – FDA – Mar 9, 1988

Doxycycline

2 approved drug products. Doxycycline Ingredients: Doxycycline Hyclate; Dosage form: injectable; Route of administration: injection; Strength: eq 100mg base/vial; Approval date: March 9, 1988; Marketing status: prescription. Doxycycline In...
Full record

US Drug Approval A062588 – FDA – Jan 6, 1986

Gentamicin Sulfate in Sodium Chloride 0.9% in Plastic Container

10 approved drug products. Gentamicin Sulfate in Sodium Chloride 0.9% in Plastic Container Ingredients: Gentamicin Sulfate; Dosage form: injectable; Route of administration: injection; Strength: eq 1.2mg base/ml; Approval date: January 6, 1986;...
Full record

US Drug Approval A062591 – FDA – Jan 10, 1986

Kefurox

3 approved drug products. Kefurox Ingredients: Cefuroxime Sodium; Dosage form: injectable; Route of administration: injection; Strength: eq 1.5gm base/vial; Approval date: January 10, 1986; Marketing status: discontinued. Kefurox Ingredien...
Full record

US Drug Approval A062593 – FDA – Aug 28, 1985

Doxycycline Hyclate

1 approved drug product. Doxycycline Hyclate Ingredients: Doxycycline Hyclate; Dosage form: tablet; Route of administration: oral; Strength: eq 100mg base; Approval date: August 28, 1985; Marketing status: discontinued.
Full record

US Drug Approval A062594 – FDA – Dec 5, 1985

Doxycycline Hyclate

2 approved drug products. Doxycycline Hyclate Ingredients: Doxycycline Hyclate; Dosage form: capsule; Route of administration: oral; Strength: eq 50mg base; Approval date: December 5, 1985; Marketing status: discontinued. Doxycycline Hyclate...
Full record

US Drug Approval A062612 – FDA – Feb 20, 1986

Gentamicin Sulfate

1 approved drug product. Gentamicin Sulfate Ingredients: Gentamicin Sulfate; Dosage form: injectable; Route of administration: injection; Strength: eq 10mg base/ml; Approval date: February 20, 1986; Marketing status: prescription.
Full record

US Drug Approval A062617 – FDA – Sep 18, 1985

Neomycin Sulfate, Polymyxin B Sulfate & Hydrocortisone

1 approved drug product. Neomycin Sulfate, Polymyxin B Sulfate & Hydrocortisone Ingredients: Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate; Dosage form: suspension/drops; Route of administration: otic; Strength: 1%;eq 3.5mg base/ml;1...
Full record

US Drug Approval A062623 – FDA – Sep 24, 1985

Neomycin Sulfate-Polymyxin B Sulfate-Hydrocortisone

1 approved drug product. Neomycin Sulfate-Polymyxin B Sulfate-Hydrocortisone Ingredients: Hydrocortisone; Neomycin Sulfate; Polymyxin B Sulfate; Dosage form: suspension/drops; Route of administration: ophthalmic; Strength: 1%;eq 3.5mg base/ml;10...
Full record